SCHEMBL6323019

SCHEMBL6323019

CC(C(N)Cc1ccc(Cl)cc1)N1CCc2ccccc21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 5/20 0.45
SLC6A2 P23975 1/20 0.43
SLC6A3 Q01959 1/20 0.43
MAPT P10636 2/20 0.42
GAA P10253 2/20 0.42
TP53 P04637 1/20 0.42
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
HTR2B P41595 1/20 0.41
DRD2 P14416 4/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
ADRA1D P25100 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
MC4R P32245 2/20 0.41
ALDH1A1 P00352 2/20 0.40
POLB P06746 1/20 0.40
TSHR P16473 1/20 0.40
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3376076 0.85 DRD4 (0.45) DRD4SLC6A2SLC6A3MAPTGAA
SCHEMBL5266467 0.80 DRD4 (0.45) DRD4SLC6A2MAPTGAATP53
SCHEMBL3525063 0.76 DRD4 (0.49) DRD4MAPTGAATP53DRD2
SCHEMBL3371790 0.72 DRD4 (0.46) DRD4MAPTGAATP53DRD2
SCHEMBL11852260 0.72 GAA (0.47) DRD4SLC6A2MAPTGAATP53
SCHEMBL21085252 0.72 ALDH1A1 (0.46) DRD4SLC6A2MAPTGAADRD2
SCHEMBL20957018 0.71 SLC6A2 (0.46) DRD4SLC6A2SLC6A3MAPTGAA
Hydrochloric Acid SCHEMBL31467512 0.70 SLC6A2 (0.47) SLC6A2SLC6A3MAPTGAATP53
SCHEMBL14060360 0.69 ALDH1A1 (0.46) DRD4SLC6A2MAPTGAADRD2
SCHEMBL1102007 0.69 ALDH1A1 (0.48) DRD4SLC6A2MAPTGAATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050154202-A1 Substituted aryl amides MERCK & CO., INC. 2005-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050154202-A1 Substituted aryl amides CNR1, CNR2, FAAH DRD4 3399/4885SLC6A2 1641/4885SLC6A3 2109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.